IGF-1 in OA progression In addition to its effects on cartilage metabolism, IGF-1 affects the development of OA in other ways
Even though they target the body differently, both offer reliable, medically supervised support for long-term weight management
This transition is accelerating due to improved bioavailability technologies and growing consumer preference for oral administration
doi:10.1210/clinem/dgaa327 59
Were seeing GLP-1 drugs show tremendous promise across a wide range of conditions, including improving markers of body-wide and brain inflammation, which is common in long COVID, says Eric Topol, executive vice president of Scripps Research and co-principal investigator of LoCITT
PRP Treatments made from ones own blood to support healing and tissue repair